Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
The Side Quest Worth Taking cover art

The Side Quest Worth Taking

The Side Quest Worth Taking

Listen for free

View show details
About this listen

When should you follow conventional wisdom and say no to a major product side quest, and how do you recognize the rare opportunity that deserves a yes?

Sella Brosh, co-founder and CEO of Nvision Quantum Technologies, expected a working prototype in two years. Bringing the company’s first product to market took almost eight. In this episode, Sella shares what it takes to turn quantum science into a business, from validating a real clinical need to repeatedly changing the technology while staying committed to the problem.

He walks through a decision that reshaped the company: branching into quantum computing, a completely different application of its technology, before its MRI imaging product was even commercially available. With every startup playbook telling him to focus, how did he decide this was an opportunity worth pursuing? Sella explains how the unique technology his team had and the size of the market opportunity made it worth pursuing, while separate teams, dedicated funding, and clear boundaries allowed Nvision to make that bet while protecting its core business. He also shares why Nvision sees itself as a quantum technology company operating in healthcare rather than a healthcare company, and how choosing which parts of the healthcare value chain to stay out of creates room for its broader ambitions.

We also dig into what it takes to lead a team of deeply expert physicists as a non-scientist and the personal cost of building a company that straddles continents.

About Sella

Sella Brosh is the co founder and Chief Executive Officer of NVision Quantum Technologies, which he has led since its inception in 2016. As CEO, he guides NVision’s mission to transform healthcare through quantum technologies, spanning quantum enhanced imaging and quantum computing.

Under his leadership, NVision developed POLARIS, a quantum enhanced metabolic MRI platform designed to bring advanced molecular imaging into real clinical environments, and expanded the company into quantum computing through PIQC, a photonic integrated quantum computing architecture based on photon emitting organic molecules.

Before co founding NVision, Dr. Brosh served as a senior engagement manager in McKinsey’s US Mid Atlantic office, where he led global commercialization efforts for major pharmaceutical and medical device companies.

Earlier in his career, Dr. Brosh was a combat engineering officer, first as a platoon commander and later as an operations officer of a combat battalion in mission critical environments. He earned his Bachelor of Medical Science, magna cum laude, and his Medical Doctor degree from Tel Aviv University.

Presented by Aytza

adbl_web_anon_alc_button_suppression_t1
No reviews yet